The Role of Tofacitinib in the Treatment of Acute Severe Colitis in Children.

Guillermo Alejandro CostagutaChloé GirardVéronique GroleauKelly GrzywaczMartha Heather DirksColette Deslandres

Published in: Journal of the Canadian Association of Gastroenterology (2023)

Tofacitinib response is rapid and impressive in children suffering from ASC, and the safety profile appears comparable to or better than other available treatments. In the future, tofacitinib should be integrated into pediatric protocols.

Keyphrases

rheumatoid arthritis
ulcerative colitis
young adults
liver failure
drug induced
early onset
current status
intensive care unit
combination therapy
aortic dissection
hepatitis b virus
smoking cessation
extracorporeal membrane oxygenation
replacement therapy